Alternative Complement Pathway Inhibition With Iptacopan for the Treatment of C3 Glomerulopathy-Study Design of the APPEAR-C3G Trial - Concepedia

Concepedia

Publication | Open Access

Alternative Complement Pathway Inhibition With Iptacopan for the Treatment of C3 Glomerulopathy-Study Design of the APPEAR-C3G Trial

DOI Full Paper Access

69

Citations

26

References

2022

Year

Andrew S. Bomback, David Kavanagh, Marina Vivarelli, Matthias Meier, Yaqin Wang, Nicholas J.A. Webb, Angelo J. Trapani, Richard J. Smith

Kidney International Reports

References

	Year	Citations

Page 1